Glutamate Synapses in Human Cognitive Disorders

Annual Review of Neuroscience

Volumn 38, Issue , 2015, Pages 127-149

  Volk, Lenora ^a   Chiu, Shu Ling ^a   Sharma, Kamal ^a   Huganir, Richard L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Excitatory; Intellectual disability; Neurodevelopmental; Plasticity; Schizophrenia

Indexed keywords

ARTICLE; AUTISM; CELL ADHESION; COGNITION; COGNITIVE DEFECT; DENDRITIC SPINE; EXECUTIVE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GLUTAMATERGIC SYNAPSE; HUMAN; INTELLECTUAL IMPAIRMENT; INTELLIGENCE; INTERPERSONAL COMMUNICATION; LONG TERM POTENTIATION; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PERCEPTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; RETT SYNDROME; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; SYNAPTIC TRANSMISSION; ANIMAL; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE;

GLUTAMIC ACID;

ANIMALS; AUTISM SPECTRUM DISORDER; COGNITION DISORDERS; GENETIC PREDISPOSITION TO DISEASE; GLUTAMIC ACID; HUMANS; INTELLECTUAL DISABILITY; MODELS, NEUROLOGICAL; SCHIZOPHRENIA; SYNAPSES;

EID: 84937409911     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev-neuro-071714-033821     Document Type: Article

References (169)

1. Abekhoukh S, Bardoni B. 2014. CYFIP family proteins between autism and intellectual disability: links with Fragile X syndrome. Front. Cell. Neurosci. 8:81
2. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. 1999. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23:185-88
3. Aoto J, Martinelli DC, Malenka RC, Tabuchi K, Sudhof TC. 2013. Presynaptic neurexin-3 alternative splicing trans-synaptically controls postsynaptic AMPA receptor trafficking. Cell 154:75-88
4. Araki Y, Zeng M, Zhang M, Huganir RL. 2015. Rapid dispersion of SynGAP from synaptic spines triggers AMPA receptor insertion and spine enlargement during LTP. Neuron 85:173-89
5. Auerbach BD, Bear MF. 2010. Loss of the fragile X mental retardation protein decouples metabotropic glutamate receptor dependent priming of long-term potentiation from protein synthesis. J. Neurophysiol. 104:1047-51
6. Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, et al. 2011. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91-95
7. Ba W, van der Raadt J, Nadif KasriN. 2013. RhoGTPase signaling at the synapse: implications for intellectual disability. Exp. Cell Res. 319:2368-74
8. Balu DT, Li Y, Puhl MD, Benneyworth MA, Basu AC, et al. 2013. Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction. PNAS 110:E2400-9
9. Behnecke A, Hinderhofer K, BartschO, Nümann A, Ipach ML, et al. 2011. Intragenic deletions of IL1RAPL1: Report of two cases and review of the literature. Am. J. Med. Genet. A 155A:372-79
10. Belforte JE, Zsiros V, Sklar ER, Jiang Z, YuG, et al. 2010. PostnatalNMDAreceptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 13:76-83
11. Belichenko PV, Oldfors A, Hagberg B, Dahlstrom A. 1994. Rett syndrome: 3-D confocal microscopy of cortical pyramidal dendrites and afferents. NeuroReport 5:1509-13
12. Beneyto M, Meador-Woodruff JH. 2006. Lamina-specific abnormalities of AMPA receptor trafficking and signaling molecule transcripts in the prefrontal cortex in schizophrenia. Synapse 60:585-98
13. Betancur C. 2011. Etiological heterogeneity in autism spectrum disorders:more than 100 genetic and genomic disorders and still counting. Brain Res. 1380:42-77
14. Bhakar AL, Dölen G, Bear MF. 2012. The pathophysiology of fragileX(and what it teaches us about synapses). Annu. Rev. Neurosci. 35:417-43
15. Bianchi V, Farisello P, Baldelli P, Meskenaite V, Milanese M, et al. 2009. Cognitive impairment in Gdi1-deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training. Hum. Mol. Genet. 18:105-17
16. Billuart P, Bienvenu T, Ronce N, des Portes V, Vinet MC, et al. 1998. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 392:923-26
17. Brennand KJ, Simone A, Jou J, Gelboin-Burkhart C, Tran N, et al. 2011. Modelling schizophrenia using human induced pluripotent stem cells. Nature 473:221-25
18. Brody SA, Conquet F, Geyer MA. 2003. Disruption of prepulse inhibition in mice lacking mGluR1. Eur. J. Neurosci. 18:3361-66
19. Camacho-Garcia RJ, Hervás A, Toma C, Balmaña N, Cormand B, et al. 2013. Rare variants analysis of neurexin-1in autism reveals a novel start codon mutation affecting protein levels at synapses. Psychiatr. Genet. 23:262-66
20. Carlisle HJ, Manzerra P, Marcora E, Kennedy MB. 2008. SynGAP regulates steady-state and activitydependent phosphorylation of cofilin. J. Neurosci. 28:13673-83
21. Caroni P, Donato F, Muller D. 2012. Structural plasticity upon learning: Regulation and functions. Nat. Rev. Neurosci. 13:478-90
22. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. 2000. Endocytic pathway abnormalities precede amyloid deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157:277-86
23. CDC (Cent. Dis. Control Prev.). 2014. Prevalence of autism spectrum disorder among children aged 8 years-Autism andDevelopmentalDisabilitiesMonitoringNetwork, 11 sites, United States, 2010. Morb. Mortal. Wkly. Rep. 63:1-21
24. Chang KT, Ro H, Wang W, Min KT. 2013. Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome. Trends Neurosci. 36:685-94
25. Chow EW, WatsonM, Young DA, Bassett AS. 2006. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr. Res. 87:270-78
26. Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, et al. 2007. Behavioral phenotypes of Disc1 missense mutations in mice. Neuron 54:387-402
27. Clement JP, Aceti M, Creson TK, Ozkan ED, Shi Y, et al. 2012. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 151:709-23
28. Clement JP, Ozkan ED, Aceti M, Miller CA, Rumbaugh G. 2013. SYNGAP1 links the maturation rate of excitatory synapses to the duration of critical-period synaptic plasticity. J. Neurosci. 33:10447-52
29. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, et al. 1997. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. PNAS 94:5401-4
30. Conquet F, Bashir ZI, Davies CH, DanielH, Ferraguti F, et al. 1994. Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1. Nature 372:237-43
31. Contractor A, Mulle C, Swanson GT. 2011. Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci. 34:154-63
32. Copits BA, Robbins JS, Frausto S, SwansonGT. 2011. Synaptic targeting and functional modulation ofGluK1 kainate receptors by the auxiliary neuropilin and tolloid-like (NETO) proteins. J. Neurosci. 31:7334-40
33. D'Adamo P, Welzl H, Papadimitriou S, Raffaele di Barletta M, Tiveron C, et al. 2002. Deletion of the mental retardation gene Gdi1 impairs associative memory and alters social behavior in mice. Hum. Mol. Genet. 11:2567-80
34. Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB. 2005. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. PNAS 102:12560-65
35. Darnell JC, Klann E. 2013. The translation of translational control by FMRP: therapeutic targets for FXS. Nat. Neurosci. 16:1530-36
36. DeLisi LE. 1992. The significance of age of onset for schizophrenia. Schizophr. Bull. 18:209-15
37. Dev KK, Henley JM. 2006. The schizophrenic faces of PICK1. Trends Pharmacol. Sci. 27:574-79
38. Ehninger D, Han S, Shilyansky C, Zhou Y, LiW, et al. 2008a. Reversal of learning deficits in a Tsc2+/ mouse model of tuberous sclerosis. Nat. Med. 14:843-48
39. Ehninger D, Li W, Fox K, Stryker MP, Silva AJ. 2008b. Reversing neurodevelopmental disorders in adults. Neuron 60:950-60
40. El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS. 2000. PSD-95 involvement in maturation of excitatory synapses. Science 290:1364-68
41. Etherton MR, Földy C, Sharma M, Tabuchi K, Liu X, et al. 2011a. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. PNAS 108:13764-69
42. Etherton MR, Tabuchi K, Sharma M, Ko J, Sudhof TC. 2011b. An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J. 30:2908-19
43. Fernández E, Collins MO, Uren RT, Kopanitsa MV, Komiyama NH, et al. 2009. Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Mol. Syst. Biol. 5:269
44. Feyder M, Karlsson RM, Mathur P, LymanM, Bock R, et al. 2010. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am. J. Psychiatry 167:1508-17
45. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, et al. 2014. De novo mutations in schizophrenia implicate synaptic networks. Nature 506:179-84
46. Fujioka R, Nii T, Iwaki A, Shibata A, Ito I, et al. 2014. Comprehensive behavioral study of mGluR3 knockout mice: implication in schizophrenia related endophenotypes. Mol. Brain 7:31
47. Gauthier J, Champagne N, Lafrenière RG, Xiong L, Spiegelman D, et al. 2010. De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. PNAS 107:7863-68
48. Gécz J, Barnett S, Liu J, Hollway G, Donnelly A, et al. 1999. Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. Genomics 62:356-68
49. Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, et al. 2010. Strong synaptic transmission impact by copy number variations in schizophrenia. PNAS 107:10584-89
50. Glynn MW, Elmer BM, Garay PA, Liu XB, Needleman LA, et al. 2011. MHCI negatively regulates synapse density during the establishment of cortical connections. Nat. Neurosci. 14:442-51
51. Goddard CA, Butts DA, Shatz CJ. 2007. Regulation of CNS synapses by neuronal MHC class I. PNAS 104:6828-33
52. Goorden SMI, van Woerden GM, van der Weerd L, Cheadle JP, Elgersma Y. 2007. Cognitive deficits in Tsc1+/ mice in the absence of cerebral lesions and seizures. Ann. Neurol. 62:648-55
53. Gottesman II, Shields J. 1967. A polygenic theory of schizophrenia. PNAS 58:199-205
54. Grabrucker AM, Knight MJ, Proepper C, Bockmann J, Joubert M, et al. 2011a. Concerted action of zinc and ProSAP/Shank in synaptogenesis and synapse maturation. EMBO J. 30:569-81
55. Grabrucker AM, Schmeisser MJ, Schoen M, Boeckers TM. 2011b. Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol. 21:594-603
56. Greer PL, Hanayama R, Bloodgood BL, Mardinly AR, Lipton DM, et al. 2010. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating Arc. Cell 140:704-16
57. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, et al. 2009. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch. Gen. Psychiatry 66:947-56
58. Haghighi M, Jahangard L, Mohammad-Beigi H, Bajoghli H, Hafezian H, et al. 2013. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). Psychopharmacology 228:633-40
59. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, et al. 2011. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68:1095-102
60. Hamdan FF, Gauthier J, Spiegelman D, Noreau A, Yang Y, et al. 2009a. Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N. Engl. J. Med. 360:599-605
61. Hamdan FF, Piton A, Gauthier J, Lortie A, Dubeau F, et al. 2009b. De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy. Ann. Neurol. 65:748-53
62. Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, et al. 2010. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13:327-32
63. Herrero I, Miras-Portugal MT, Sánchez-Prieto J. 1992. Positive feedback of glutamate exocytosis by metabotropic presynaptic receptor stimulation. Nature 360:163-66
64. Huganir RL, Nicoll RA. 2013. AMPARs and synaptic plasticity: the last 25 years. Neuron 80:704-17
65. Huguet G, Ey E, Bourgeron T. 2013. The genetic landscapes of autism spectrum disorders. Annu. Rev. Genomics Hum. Genet. 14:191-213
66. Huh GS, Boulanger LM, Du H, Riquelme PA, Brotz TM, Shatz CJ. 2000. Functional requirement for class I MHC in CNS development and plasticity. Science 290:2155-59
67. Hussain NK, Diering GH, Sole J, Anggono V, Huganir RL. 2014. Sorting Nexin 27 regulates basal and activity-dependent trafficking of AMPARs. PNAS 111:11840-45
68. Hutsler JJ, Zhang H. 2010. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309:83-94
69. Irwin SA, Patel B, IdupulapatiM, Harris JB, Crisostomo RA, et al. 2001. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination. Am. J. Med. Genet. 98:161-67
70. Jamain S, Radyushkin K, Hammerschmidt K, Granon S, Boretius S, et al. 2008. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. PNAS 105:1710-15
71. Jaramillo TC, Liu S, Pettersen A, Birnbaum SG, Powell CM. 2014. Autism-related neuroligin-3 mutation alters social behavior and spatial learning. Autism Res. 7:264-72
72. Jiang Y, Ehlers MD. 2013. Modeling autism by SHANK gene mutations in mice. Neuron 78:8-27
73. Kellendonk C, Simpson EH, Kandel ER. 2009. Modeling cognitive endophenotypes of schizophrenia inmice. Trends Neurosci. 32:347-58
74. Kessels HW, Malinow R. 2009. Synaptic AMPA receptor plasticity and behavior. Neuron 61:340-50
75. Khelfaoui M, Denis C, van Galen E, de Bock F, Schmitt A, et al. 2007. Loss of X-linked mental retardation gene oligophrenin1 in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. J. Neurosci. 27:9439-50
76. Kim JH, LeeHK, Takamiya K, HuganirRL. 2003. The role of synapticGTPase-activating protein in neuronal development and synaptic plasticity. J. Neurosci. 23:1119-24
77. Kim JH, Liao D, Lau LF, Huganir RL. 1998. SynGAP: A synaptic RasGAP that associates with the PSD-95/SAP90 protein family. Neuron 20:683-91
78. Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, et al. 2012. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17:142-53
79. Kishino T, Lalande M, Wagstaff J. 1997. UBE3A/E6-AP mutations cause Angelman syndrome. Nat. Genet. 15:70-73
80. Komiyama NH, Watabe AM, Carlisle HJ, Porter K, Charlesworth P, et al. 2002. SynGAP regulates ERK/MAPK signaling, synaptic plasticity, and learning in the complex with postsynaptic density 95 and NMDA receptor. J. Neurosci. 22:9721-32
81. KrummN, O'Roak BJ, Shendure J, Eichler EE. 2014. A de novo convergence of autism genetics andmolecular neuroscience. Trends Neurosci. 37:95-105
82. Labrie V, Wong AH, Roder JC. 2012. Contributions of the D-serine pathway to schizophrenia. Neuropharmacology 62:1484-503
83. Lejeune J, Gautier M, Turpin R. 1959. Étude des chromosomes somatiques de neuf enfants mongoliens. C. R. Acad. Sci. 248:1721-22
84. LoganWJ, Snyder SH. 1971. Unique high affinity uptake systems for glycine, glutamic and aspartic acids in central nervous tissue of the rat. Nature 234:297-99
85. Lonart G. 2002. RIM1: An edge for presynaptic plasticity. Trends Neurosci. 25:329-32
86. Luo P, Li X, FeiZ, PoonW. 2012. Scaffold proteinHomer 1: implications for neurological diseases. Neurochem. Int. 61:731-38
87. Luscher C, Huber KM. 2010. Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65:445-59
88. Mabb AM, Judson MC, Zylka MJ, Philpot BD. 2011. Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci. 34:293-303
89. Margolis SS, Salogiannis J, LiptonDM, Mandel-Brehm C, Wills ZP, et al. 2010. EphB-mediated degradation of theRhoAGEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell 143:442-55
90. McCarroll SA, Feng G, Hyman SE. 2014. Genome-scale neurogenetics: methodology and meaning. Nat. Neurosci. 17:756-63
91. McMahon SA, Dáz E. 2011. Mechanisms of excitatory synapse maturation by trans-synaptic organizing complexes. Curr. Opin. Neurobiol. 21:221-27
92. Mejias R, Adamczyk A, Anggono V, Niranjan T, Thomas GM, et al. 2011. Gain-of-function glutamate receptor interacting protein 1 variants alter GluA2 recycling and surface distribution in patients with autism. PNAS 108:4920-25
93. Miles JH. 2011. Autism spectrum disorders-a genetics review. Genet. Med. 13:278-94
94. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, et al. 2000. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9:1415-23
95. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. 1999. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-36
96. MoralesM, VarlinskayaEI, SpearLP. 2013. Low doses of theNMDAreceptor antagonists, MK-801, PEAQX, and ifenprodil, induces social facilitation in adolescent male rats. Behav. Brain Res. 250:18-22
97. Mukai J, Dhilla A, Drew LJ, Stark KL, Cao L, et al. 2008. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nat. Neurosci. 11:1302-10
98. Mukai J, Liu H, Burt RA, Swor DE, Lai WS, et al. 2004. Evidence that the gene encoding ZDHHC8 contributes to the risk of schizophrenia. Nat. Genet. 36:725-31
99. NadifKasri N, Nakano-Kobayashi A, Malinow R, Li B, Van Aelst L. 2009. The Rho-linkedmental retardation protein oligophrenin-1 controls synapse maturation and plasticity by stabilizing AMPA receptors. Genes Dev. 23:1289-302
100. Naisbitt S, Kim E, Tu JC, Xiao B, Sala C, et al. 1999. Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin. Neuron 23:569-82
101. Nakano-Kobayashi A, Nadif Kasri N, Newey SE, Van Aelst L. 2009. The Rho-linked mental retardation protein OPHN1 controls synaptic vesicle endocytosis via endophilin A1. Curr. Biol. 19:1133-39
102. Nelson PA, Sage JR, Wood SC, DavenportCM, Anagnostaras SG, BoulangerLM. 2013. MHCclass I immune proteins are critical for hippocampus-dependent memory and gate NMDAR-dependent hippocampal long-term depression. Learn. Mem. 20:505-17
103. Nemeroff CB, Weinberger D, Rutter M, MacMillan HL, Bryant RA, et al. 2013. DSM-5: A collection of psychiatrist views on the changes, controversies, and future directions. BMC Med. 11:202
104. Newpher TM, Ehlers MD. 2008. Glutamate receptor dynamics in dendriticmicrodomains. Neuron 58:472-97
105. Nicoll RA, Tomita S, Bredt DS. 2006. Auxiliary subunits assist AMPA-type glutamate receptors. Science 311:1253-56
106. Niswender CM, Conn PJ. 2010. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol. 50:295-322
107. O'Brien RJ, Kamboj S, Ehlers MD, Rosen KR, Fischbach GD, Huganir RL. 1998. Activity-dependent modulation of synaptic AMPA receptor accumulation. Neuron 21:1067-78
108. Ohi K, Hashimoto R, Ikeda M, Yamamori H, Yasuda Y, et al. 2014. Glutamate networks implicate cognitive impairments in schizophrenia: genome-wide association studies of 52 cognitive phenotypes. Schizophr. Bull. In press. doi: 10. 1093/schbul/
109. Ohno T, Maeda H, Murabe N, Kamiyama T, Yoshioka N, et al. 2010. Specific involvement of postsynaptic GluN2B-containingNMDAreceptors in the developmental elimination of corticospinal synapses. PNAS 107:15252-57
110. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, et al. 2012. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338:1619-22
111. Pavlowsky A, Gianfelice A, Pallotto M, Zanchi A, Vara H, et al. 2010. A postsynaptic signaling pathway that may account for the cognitive defect due to IL1RAPL1 mutation. Curr. Biol. : CB 20:103-15
112. Pfeiffer BE, Huber KM. 2007. Fragile X mental retardation protein induces synapse loss through acute postsynaptic translational regulation. J. Neurosci. 27:3120-30
113. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, et al. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-22
114. Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, et al. 2014. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506:185-90
115. Rabaneda LG, Robles-Lanuza E, Nieto-González JL, Scholl FG. 2014. Neurexin dysfunction in adult neurons results in autistic-like behavior in mice. Cell Rep. 8:338-46
116. Radyushkin K, Hammerschmidt K, Boretius S, Varoqueaux F, El-Kordi A, et al. 2009. Neuroligin-3-deficient mice:model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav. 8:416-25
117. Ramanathan S, Woodroffe A, Flodman PL, Mays LZ, Hanouni M, et al. 2004. A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamine and glycine neurotransmitter receptor sub-units (AMPA 2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R. BMC Med. Genet. 5:10
118. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, et al. 1995. Amousemodel for Down syndrome exhibits learning and behaviour deficits. Nat. Genet. 11:177-84
119. Ricceri L, De Filippis B, Laviola G. 2008. Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav. Pharmacol. 19:501-17
120. Rinaldi T, Kulangara K, Antoniello K, Markram H. 2007. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. PNAS 104:13501-506
121. Rojas D. 2014. The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment. J. Neural Transm. 121:891-905
122. Saitsu H, Kato M, Mizuguchi T, Hamada K, Osaka H, et al. 2008. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat. Genet. 40:782-88
123. Sakimura K, Kutsuwada T, Ito I, Manabe T, Takayama C, et al. 1995. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor 1 subunit. Nature 373:151-55
124. Sala C, Piëch V, Wilson NR, Passafaro M, Liu G, Sheng M. 2001. Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31:115-30
125. Sanz-Clemente A, Nicoll RA, Roche KW. 2013. Diversity in NMDA receptor composition: many regulators, many consequences. Neuroscientist 19:62-75
126. Scheiffele P, Fan J, Choih J, Fetter R, Serafini T. 2000. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101:657-69
127. Schizophr. Work. Group Psychiatr. Genomics Consort. 2014. Biological insights from 108 schizophreniaassociated genetic loci. Nature 511:421-27
128. Schmeisser MJ, Ey E, Wegener S, Bockmann J, Stempel AV, et al. 2012. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486:256-60
129. Schneider T, Przewlocki R. 2005. Behavioral alterations in rats prenatally exposed to valproic acid: Animal model of autism. Neuropsychopharmacology 30:80-89
130. Schwenk J, Harmel N, Zolles G, Bildl W, Kulik A, et al. 2009. Functional proteomics identify cornichon proteins as auxiliary subunits of AMPA receptors. Science 323:1313-19
131. Seeman P, Lee T. 1975. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188:1217-19
132. Shatz CJ. 2009. MHC class I: An unexpected role in neuronal plasticity. Neuron 64:40-45
133. Shcheglovitov A, Shcheglovitova O, Yazawa M, Portmann T, Shu R, et al. 2013. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients. Nature 503:267-71
134. Sheng M, Cummings J, Roldan LA, Jan YN, Jan LY. 1994. Changing subunit composition of heteromeric NMDA receptors during development of rat cortex. Nature 368:144-47
135. Shepherd JD, Huganir RL. 2007. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu. Rev. Cell Dev. Biol. 23:613-43
136. Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, et al. 2006. Arc/Arg3. 1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron 52:475-84
137. Sidorov MS, Auerbach BD, BearMF. 2013. Fragile X mental retardation protein and synaptic plasticity. Mol. Brain 6:15
138. Smith SEP, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP. 2011. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci. Transl. Med. 3:103ra97
139. Soorya L, Kolevzon A, Zweifach J, Lim T, Dobry Y, et al. 2013. Prospective investigation of autism and genotype-phenotype correlations in 22q13 deletion syndrome and SHANK3 deficiency. Mol. Autism 4:18
140. Soto D, Altafaj X, Sindreu C, Bayes A. 2014. Glutamate receptor mutations in psychiatric and neurodevelopmental disorders. Commun. Integr. Biol. 7:e27887
141. Spencer CM, Alekseyenko O, Hamilton SM, Thomas AM, Serysheva E, et al. 2011. Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses. Autism Res. 4:40-56
142. Srivastava AK, Schwartz CE. 2014. Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms. Neurosci. Biobehav. Rev. 46:161-74
143. Sturgeon X, Gardiner KJ. 2011. Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions. Mamm. Genome 22:261-71
144. Sudhof TC. 2008. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455:903-11
145. Sudhof TC. 2013. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron 80:675-90
146. Sullivan PF. 2013. Questions about DISC1 as a genetic risk factor for schizophrenia. Mol. Psychiatry 18:1050-52
147. Swerdlow NR, GeyerMA. 1998. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24:285-301
148. Tang G, Gudsnuk K, Kuo S-H, Cotrina Marisa L, Rosoklija G, et al. 2014. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron 83:1131-43
149. Tarabeux J, Kebir O, Gauthier J, Hamdan FF, Xiong L, et al. 2011. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl. Psychiatry 1:e55
150. Terashima A, Pelkey KA, Rah JC, Suh YH, Roche KW, et al. 2008. An essential role for PICK1 in NMDA receptor-dependent bidirectional synaptic plasticity. Neuron 57:872-82
151. Thornberg SA, Saklad SR. 1996. A review ofNMDAreceptors and the phencyclidinemodel of schizophrenia. Pharmacotherapy 16:82-93
152. Toonen RFG, Wierda K, Sons MS, deWit H, Cornelisse LN, et al. 2006. Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size. PNAS 103:18332-37
153. Toro C, Deakin JF. 2005. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr. Res. 80:323-30
154. Troca-Marń JA, Alves-Sampaio A, Montesinos ML. 2012. Deregulated mTOR-mediated translation in intellectual disability. Prog. Neurobiol. 96:268-82
155. Tsai G, Coyle JT. 2002. Glutamatergicmechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol. 42:165-79
156. Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, et al. 2012. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488:647-51
157. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, et al. 1999. Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23:583-92
158. Turrigiano GG, Leslie KR, Desai NS, Rutherford LC, Nelson SB. 1998. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 391:892-96
159. Tzingounis AV, Nicoll RA. 2006. Arc/Arg3. 1: linking gene expression to synaptic plasticity and memory. Neuron 52:403-7
160. Vaags AK, Lionel AC, Sato D, GoodenbergerM, Stein QP, et al. 2012. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am. J. Hum. Genet. 90:133-41
161. van Bokhoven H. 2011. Genetic and epigenetic networks in intellectual disabilities. Annu. Rev. Genet. 45:81-104
162. Verhage M, Maia AS, Plomp JJ, Brussaard AB, Heeroma JH, et al. 2000. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 287:864-69
163. Volk L, Kim CH, Takamiya K, Yu Y, Huganir RL. 2010. Developmental regulation of protein interacting with C kinase 1 (PICK1) function in hippocampal synaptic plasticity and learning. PNAS 107:21784-89
164. von Engelhardt J, Doganci B, JensenV, HvalbyO, Göngrich C, et al. 2008. Contribution of hippocampal and extra-hippocampal NR2B-containing NMDA receptors to performance on spatial learning tasks. Neuron 60:846-60
165. Waltes R, Gfesser J, Haslinger D, Schneider-Momm K, Biscaldi M, et al. 2014. Common EIF4E variants modulate risk for autism spectrum disorders in the high-functioning range. J. Neural Transm. 121:1107-16
166. Wang CC, Held RG, Chang SC, Yang L, Delpire E, et al. 2011. A critical role forGluN2B-containingNMDA receptors in cortical development and function. Neuron 72:789-805
167. Wang X, Zhao Y, Zhang X, Badie H, Zhou Y, et al. 2013. Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction bymodulating glutamate receptor recycling inDown's syndrome. Nat. Med. 19:473-80
168. Wiedholz LM, Owens WA, Horton RE, Feyder M, Karlsson RM, et al. 2008. Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol. Psychiatry 13:631-40
169. Yasumura M, Yoshida T, YamazakiM, Abe M, Natsume R, et al. 2014. IL1RAPL1 knockout mice show spine density decrease, learning deficiency, hyperactivity and reduced anxiety-like behaviours. Sci. Rep. 4:6613